<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="fevr" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">fevr</book-part-id>
      <title-group>
        <title>Familial Exudative Vitreoretinopathy, Autosomal Dominant</title>
        <alt-title alt-title-type="alt-title">Synonym: adFEVR</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Toomes</surname>
            <given-names>Carmel</given-names>
          </name>
          <xref ref-type="aff" rid="fevr.AFF1"/>
          <degrees>PhD, BSc</degrees>
          <email>c.toomes@leeds.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Downey</surname>
            <given-names>Louise</given-names>
          </name>
          <xref ref-type="aff" rid="fevr.AFF2"/>
          <degrees>PhD, BSc, MBChB, FRCOphth</degrees>
          <email>downeylouise@hotmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="fevr.AFF1">Royal Society Principal Research Fellow<break/>Honorary Associate Professor<break/>Section of Ophthalmology and Neuroscience<break/>Leeds Institute of Molecular Medicine<break/>University of Leeds<break/>Leeds, United Kingdom </aff>
      <aff id="fevr.AFF2">Consultant in Ophthalmology <break/>Hull Royal Infirmary<break/>Kingston upon Hull, United Kingdom</aff>
      <pub-history>
        <date iso-8601-date="2005-03-21" date-type="created">
          <day>21</day>
          <month>03</month>
          <year>2005</year>
        </date>
        <date iso-8601-date="2011-07-14" date-type="updated">
          <day>14</day>
          <month>07</month>
          <year>2011</year>
        </date>
        <date iso-8601-date="2011-09-22" date-type="revised">
          <day>22</day>
          <month>09</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="fd" document-type="chapter">Familial Dysautonomia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="fhm" document-type="chapter">Familial Hemiplegic Migraine</related-object>
      <abstract id="fevr.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Autosomal dominant familial exudative vitreoretinopathy (adFEVR) is characterized by failure of peripheral retinal vascularization. The visual problems and variable phenotype associated with adFEVR result from secondary complications caused by retinal ischemia. The retinal avascularity is probably present from birth and generates sequelae that stabilize in early adult life or progress in later life. Expressivity may be asymmetric and is highly variable, ranging from mild or asymptomatic to severe (e.g., registered as blind) within the same family. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of adFEVR is based on a family history compatible with autosomal dominant inheritance and bilateral peripheral retinal avascularity, seen temporally, by indirect ophthalmoscope and scleral indentation, or by fundus fluorescein angiography. Mutations in one of three genes are known to be associated with adFEVR: <italic toggle="yes">FZD4</italic>, encoding the protein frizzled-4; <italic toggle="yes">LRP5</italic>, encoding low-density lipoprotein receptor-related protein 5; and <italic toggle="yes">TSPAN12</italic>, encoding tetraspanin-12. Mutations in these genes are responsible for fewer than 50% of adFEVR cases. Another locus, EVR3, has been mapped; the gene is not known. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Prophylactic cryotherapy or argon laser photocoagulation to induce regression of new vessel growth caused by ischemia resulting from retinal avascularity; treatment is similar for retinal holes and areas of retinal exudate to prevent retinal detachment; rhegmatogenous retinal detachments produced by retinal traction are repaired surgically using conventional methods and exudative retinal detachments may be stabilized with cryotherapy, but prognosis is guarded for both. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Reduced bone density would be expected to benefit from drugs used to treat osteoporosis; however, long-term follow-up data are not yet available. </p>
          <p><italic toggle="yes">Surveillance:</italic> Regular fundus examination in children to evaluate for neovascularization, traction, or exudate; review of individuals with retinal traction at intervals determined by the clinical findings. </p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Fundus examination and fundus fluorescein angiography to identify characteristic lesions to allow early treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Autosomal dominant FEVR is inherited in an autosomal dominant manner. Offspring of an affected individual are at a 50% risk of inheriting the mutation, but many individuals with adFEVR can be asymptomatic because of reduced penetrance. Prenatal testing is possible if the disease-causing mutation has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="fevr.Diagnosis">
        <title>Diagnosis</title>
        <sec id="fevr.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of autosomal dominant familial exudative vitreoretinopathy (adFEVR) is based on the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Family history compatible with autosomal dominant inheritance </p>
            </list-item>
            <list-item>
              <p>Bilateral peripheral retinal avascularity (<xref ref-type="fig" rid="fevr.F1">Figure 1</xref>) </p>
              <list list-type="bullet">
                <list-item>
                  <p>Retinal avascularity is usually seen temporally, but may be missed unless an indirect ophthalmoscope and scleral indentation are used. </p>
                </list-item>
                <list-item>
                  <p>Retinal vascular changes may be more apparent with fundus fluorescein angiography; one small study has suggested that this method identifies 100% of FEVR cases [<xref ref-type="bibr" rid="fevr.REF.ober.1980.112">Ober et al 1980</xref>]. </p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Other retinal abnormalities that support the diagnosis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Retinal neovascularization and peripheral brush border anastomoses </p>
            </list-item>
            <list-item>
              <p>Peripheral fibrovascular mass </p>
            </list-item>
            <list-item>
              <p>Retinal holes/tears that may be associated with retinal detachment </p>
            </list-item>
            <list-item>
              <p>Retinal traction (with macular ectopia and/or straightening of vessels at the posterior pole, acute-angle vascular branching) that may be associated with retinal detachment </p>
            </list-item>
            <list-item>
              <p>Exudation that may be associated with retinal detachment </p>
            </list-item>
            <list-item>
              <p>Falciform retinal folds </p>
            </list-item>
          </list>
          <p>Rare retinal features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Retinoschisis </p>
            </list-item>
            <list-item>
              <p>Giant retinal tears </p>
            </list-item>
          </list>
          <p>No characteristic electrophysiologic features have been identified. </p>
        </sec>
        <sec id="fevr.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Genes.</bold> To date, mutations in one of three genes are known to be associated with adFEVR: </p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">FZD4</italic>, encoding the protein frizzled-4 [<xref ref-type="bibr" rid="fevr.REF.robitaille.2002.326">Robitaille et al 2002</xref>] </p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">LRP5</italic>, encoding low-density lipoprotein receptor-related protein 5 [<xref ref-type="bibr" rid="fevr.REF.toomes.2004a.721">Toomes et al 2004a</xref>] </p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">TSPAN12,</italic> encoding tetraspanin-12 [<xref ref-type="bibr" rid="fevr.REF.poulter.2010.248">Poulter et al 2010</xref>, <xref ref-type="bibr" rid="fevr.REF.nikopoulos.2010b.240">Nikopoulos et al 2010b</xref>]</p>
            </list-item>
          </list>
          <p>The proportion of adFEVR attributed to mutations in each of the genes varies by study:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">FZD4.</italic></bold> In the original <italic toggle="yes">FZD4</italic> identification study, mutations were identified in 40% (2/5) of cases [<xref ref-type="bibr" rid="fevr.REF.robitaille.2002.326">Robitaille et al 2002</xref>]. Most <italic toggle="yes">FZD4</italic> screening studies have found mutation rates of between 20%-40% although a few studies have found much lower detection rates. Major studies are listed below:</p>
              <list list-type="bullet">
                <list-item>
                  <p>20% (5/24) [<xref ref-type="bibr" rid="fevr.REF.kondo.2003.1291">Kondo et al 2003</xref>]</p>
                </list-item>
                <list-item>
                  <p>20% (8/40) [<xref ref-type="bibr" rid="fevr.REF.toomes.2004b.2083">Toomes et al 2004b</xref>]</p>
                </list-item>
                <list-item>
                  <p>7% (1/13) [<xref ref-type="bibr" rid="fevr.REF.macdonald.2005.363">MacDonald et al 2005</xref>]</p>
                </list-item>
                <list-item>
                  <p>3% (2/56) [<xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>]</p>
                </list-item>
                <list-item>
                  <p>3% (3/53) [<xref ref-type="bibr" rid="fevr.REF.nallathambi.2006.1086">Nallathambi et al 2006</xref>]</p>
                </list-item>
                <list-item>
                  <p>14% (9/63) [<xref ref-type="bibr" rid="fevr.REF.drenser.2009.1649">Drenser et al 2009</xref>]</p>
                </list-item>
                <list-item>
                  <p>40% (8/20) [<xref ref-type="bibr" rid="fevr.REF.boonstra.2009.4379">Boonstra et al 2009</xref>]</p>
                </list-item>
                <list-item>
                  <p>31% (5/16) [<xref ref-type="bibr" rid="fevr.REF.nikopoulos.2010a.656">Nikopoulos et al 2010a</xref>]</p>
                </list-item>
                <list-item>
                  <p>31% (15/48) [<xref ref-type="bibr" rid="fevr.REF.jia.2010.1341">Jia et al 2010</xref>]</p>
                </list-item>
                <list-item>
                  <p>17% (12/68) [<xref ref-type="bibr" rid="fevr.REF.robitaille.2011.574">Robitaille et al 2011</xref>]</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">LRP5.</italic></bold> In the original gene identification study, <italic toggle="yes">LRP5</italic> mutations were responsible for 18% (6/32) of cases [<xref ref-type="bibr" rid="fevr.REF.toomes.2004a.721">Toomes et al 2004a</xref>]. Further studies have found mutation rates between 10% and 25% (7/56, 2/20 and 4/16) [<xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>, <xref ref-type="bibr" rid="fevr.REF.boonstra.2009.4379">Boonstra et al 2009</xref>, <xref ref-type="bibr" rid="fevr.REF.nikopoulos.2010a.656">Nikopoulos et al 2010a</xref>]. </p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">TSPAN12.</italic></bold> Two teams identified <italic toggle="yes">TSPAN12</italic>. In the study by Poulter et al mutations were detected in 10% (7/70) of affected individuals. This figure is likely to be high as the cohort screened in this study had already been screened for mutations in the other FEVR-related genes [<xref ref-type="bibr" rid="fevr.REF.poulter.2010.248">Poulter et al 2010</xref>]. In the study by Nikopoulos et al mutations were detected in 45% (5/11) of individuals. This figure is probably not a true reflection of <italic toggle="yes">TSPAN12</italic> mutation frequency as the same mutation was detected in four of these families, indicating the presence of a founder mutation. Only one subsequent study has been undertaken, showing a detection rate of 3% (3/90) [<xref ref-type="bibr" rid="fevr.REF.kondo.2011.1095">Kondo et al 2011</xref>].</p>
            </list-item>
          </list>
          <p><bold>Evidence for further locus heterogeneity.</bold> A fourth locus for adFEVR, EVR3 (chromosomal locus 11p12-p13), has been mapped; the gene is not yet known [<xref ref-type="bibr" rid="fevr.REF.downey.2001.778">Downey et al 2001</xref>]. </p>
          <p><bold>Clinical testing</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">FZD4.</italic></bold> Sequence analysis of <italic toggle="yes">FZD4</italic> has identified various types of mutations (missense, nonsense, small deletions, small insertions); no splice mutations have been reported. The mutations appear to be evenly distributed throughout the gene. No mutational hot spots have been identified. </p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">LRP5.</italic></bold> Sequence analysis of <italic toggle="yes">LRP5</italic> has identified many types of mutations (missense, nonsense, small deletions, small insertions, splicing). The mutations appear to be evenly distributed throughout the gene. No mutational hot spots have been identified. Each mutation appears to be family specific. </p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">TSPAN12.</italic></bold> Sequence analysis of <italic toggle="yes">TSPAN12</italic> has identified all types of mutations (missense, nonsense, small deletions, small insertions, splicing). The mutations appear to be evenly distributed throughout the gene. No mutational hot spots have been identified. Each mutation appears to be family specific with the exception of <xref ref-type="table" rid="fevr.T.selected_tspan12_pathogenic_varia">c.709G&#x0003e;C</xref> (p.Ala237Pro), which is common in the Netherlands.</p>
            </list-item>
          </list>
          <table-wrap id="fevr.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Familial Exudative Vitreoretinopathy, Autosomal Dominant</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Proportion of adFEVR Attributed to Mutations in This Gene</th>
                  <th id="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                </tr>
                <tr>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">FZD4</italic>
                  </td>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">4%-40%</td>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="3" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="3" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">LRP5</italic>
                  </td>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">12%-25%</td>
                </tr>
                <tr>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">TSPAN12</italic>
                  </td>
                  <td headers="hd_b_fevr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">3%-10%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="fevr.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="fevr" object-id="fevr.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. </p>
              </fn>
              <fn id="fevr.TF.1.1">
                <label>2.</label>
                <p>See <xref ref-type="sec" rid="fevr.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="fevr.TF.1.2">
                <label>3.</label>
                <p>Mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="fevr.Testing_Strategy">
          <title>Testing Strategy </title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The diagnosis of adFEVR is based on a family history compatible with autosomal dominant inheritance and bilateral peripheral retinal avascularity, seen temporally, by indirect ophthalmoscope and scleral indentation, or by fundus fluorescein angiography.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing should begin with sequence analysis of <italic toggle="yes">FZD4.</italic>
</p>
            </list-item>
            <list-item>
              <p>If a pathogenic mutation is not identified, sequence analysis of <italic toggle="yes">LRP5</italic> should be performed. </p>
            </list-item>
            <list-item>
              <p>If a pathogenic mutation is not identified, sequence analysis of <italic toggle="yes">TSPAN12</italic> should be performed. </p>
            </list-item>
            <list-item>
              <p>Because not all genes associated with adFEVR are known, failure to identify a mutation in <italic toggle="yes">FZD4</italic>, <italic toggle="yes">LRP5</italic> or <italic toggle="yes">TSPAN1</italic>2 does not rule out the diagnosis. </p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutation in the family.</p>
        </sec>
      </sec>
      <sec id="fevr.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="fevr.Natural_History">
          <title>Clinical Description</title>
          <p>All individuals with autosomal dominant familial exudative vitreoretinopathy (adFEVR) have failure of peripheral retinal vascularization, which by itself usually causes no clinical symptoms. The visual problems and variable phenotype associated with adFEVR result from secondary complications caused by retinal ischemia. This region of retinal avascularity is presumed to be present from birth and initially was thought to generate sequelae that stabilized in early adult life [<xref ref-type="bibr" rid="fevr.REF.ober.1980.112">Ober et al 1980</xref>, <xref ref-type="bibr" rid="fevr.REF.tasman.1981.211">Tasman et al 1981</xref>]. Later studies suggested that disease may progress into later life [<xref ref-type="bibr" rid="fevr.REF.shukla.2003.323">Shukla et al 2003</xref>]. </p>
          <p>Autosomal dominant FEVR shows highly variable expressivity and may be markedly asymmetric. The phenotype ranges from mild to severe even within the same family. At the mild end of the spectrum, individuals are asymptomatic; at the severe end, children are registered as blind shortly after birth.</p>
          <p>Forty-one percent of the individuals reported by <xref ref-type="bibr" rid="fevr.REF.shukla.2003.323">Shukla et al [2003]</xref> were at the mild end of the spectrum, in which vision is normal; the only manifestation was an asymptomatic sector of peripheral retinal avascularity. A proportion of individuals demonstrate retinal exudates and retinal traction; about 20% develop rhegmatogenous retinal detachment [<xref ref-type="bibr" rid="fevr.REF.miyakubo.1984.1524">Miyakubo et al 1984</xref>, <xref ref-type="bibr" rid="fevr.REF.vannouhuys.1991.34">van Nouhuys 1991</xref>]. Individuals with this severe phenotype often present in the first ten years of life with reduced vision, strabismus, and/or leukocoria. </p>
          <p>Individuals with adFEVR and mutations in <italic toggle="yes">LRP5</italic> have been observed to have reduced bone mass [<xref ref-type="bibr" rid="fevr.REF.toomes.2004a.721">Toomes et al 2004a</xref>, <xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>]. Preliminary studies indicate that this finding is not seen in individuals with FEVR who have <italic toggle="yes">FZD4</italic> mutations or those with other forms of FEVR [<xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>; Toomes, personal communication]. Reduced bone mass is often evident only upon examination and predisposes affected individuals to bone fractures. </p>
        </sec>
        <sec id="fevr.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Although the phenotype has appeared to be indistinguishable by gene involved, research suggests that individuals with adFEVR who have mutations within <italic toggle="yes">LRP5</italic> may show signs of osteopenia or osteoporosis on dual x-ray absorptiometry (DXA) [<xref ref-type="bibr" rid="fevr.REF.toomes.2004a.721">Toomes et al 2004a</xref>, <xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>].</p>
          <p><bold>Possible complex inheritance of FEVR.</bold> A family with mutations in both <italic toggle="yes">FZD4</italic> (<xref ref-type="table" rid="fevr.T.selected_fzd4_pathogenic_variants">c.1250G&#x0003e;A</xref>; p.Arg417Gln) and <italic toggle="yes">LRP5</italic> (<xref ref-type="table" rid="fevr.T.selected_lrp5_pathogenic_variants">c.1330C&#x0003e;T</xref>; p.Arg444Cys) in <italic toggle="yes">cis</italic> configuration on the same chromosome had a more severe phenotype than another unrelated family with the same <italic toggle="yes">FZD4</italic> mutation only [<xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>]. Three of four affected family members with both mutations were blind, whereas three of four affected family members with only the <italic toggle="yes">FZD4</italic> mutation were asymptomatic. These findings suggest synergy between the <italic toggle="yes">FZD4</italic> mutation (p.Arg417Gln) and the <italic toggle="yes">LRP5</italic> mutation (p.Arg444Cys) in the adFEVR phenotype [<xref ref-type="bibr" rid="fevr.REF.qin.2005.104">Qin et al 2005</xref>]. </p>
          <p>In a family with FEVR with an <italic toggle="yes">FZD4</italic> mutation <xref ref-type="table" rid="fevr.T.selected_fzd4_pathogenic_variants">c.1463G&#x0003e;A</xref> (p.Gly488Asp), one affected individual had an <italic toggle="yes">FZD4</italic> sequence variant <xref ref-type="table" rid="fevr.T.selected_fzd4_pathogenic_variants">c.205C&#x0003e;T</xref> (p.His69Tyr) in <italic toggle="yes">trans</italic> configuration associated with a more severe ocular phenotype than that in family members with the p.Gly488Asp mutation only [<xref ref-type="bibr" rid="fevr.REF.kondo.2003.1291">Kondo et al 2003</xref>]. This p.His69Tyr variant was also found in controls and in another family with adFEVR [<xref ref-type="bibr" rid="fevr.REF.omoto.2004.81">Omoto et al 2004</xref>]. The proband of the family reported by <xref ref-type="bibr" rid="fevr.REF.omoto.2004.81">Omoto et al [2004]</xref> had a severe phenotype at age six years, while her affected mother and brother had a mild subclinical form of the disease.</p>
          <p>Early data suggesting that the <related-object link-type="booklink" source-id="gene" document-id="factor-v-leiden" document-type="chapter">factor V Leiden</related-object> mutation could be modifying the phenotype was not supported by subsequent studies. The cosegregation of an <italic toggle="yes">FZD4</italic> mutation <xref ref-type="table" rid="fevr.T.selected_fzd4_pathogenic_variants">c.1502delCT</xref> and the factor V Leiden mutation in a family with a severe adFEVR phenotype suggested that the factor V Leiden mutation could be modifying the phenotype [<xref ref-type="bibr" rid="fevr.REF.shastry.2004.79">Shastry &#x00026; Trese 2004</xref>]. However, the report of a second family with the same <italic toggle="yes">FZD4</italic> mutation and a severe FEVR phenotype but without the Leiden mutation [<xref ref-type="bibr" rid="fevr.REF.bottomley.2006.6">Bottomley et al 2006</xref>] suggested that the cosegregation of these two mutations in the first family was the result of chance alone. This conclusion was further supported by the failure of <xref ref-type="bibr" rid="fevr.REF.bottomley.2006.6">Bottomley et al [2006]</xref> to identify a factor V Leiden mutation in 14 additional families with adFEVR.</p>
        </sec>
        <sec id="fevr.Penetrance">
          <title>Penetrance</title>
          <p>When using fluorescein angiography to determine clinical status, penetrance is reported to be 100% because all affected individuals have a sector of avascular peripheral retina [<xref ref-type="bibr" rid="fevr.REF.ober.1980.112">Ober et al 1980</xref>]. </p>
          <p>Using examination of the retina with an indirect ophthalmoscope through a dilated pupil to determine clinical status, penetrance is considered to be about 90% [<xref ref-type="bibr" rid="fevr.REF.vannouhuys.1982.1">van Nouhuys 1982</xref>]. </p>
          <p>Using reduced vision or other clinical symptoms to determine clinical status, penetrance as low as 10% is reported.</p>
        </sec>
        <sec id="fevr.Prevalence">
          <title>Prevalence</title>
          <p>FEVR is often described as a very rare disorder. The prevalence has not been calculated; however, given that molecular testing has shown that as many as 90% of affected individuals may be asymptomatic, it is likely that the frequency of the disorder is underestimated. </p>
          <p>FEVR has been described in all ethnic groups.</p>
        </sec>
      </sec>
      <sec id="fevr.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Mutation of <italic toggle="yes">LRP5</italic> is known to cause two autosomal recessive disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal recessive FEVR (arFEVR) [<xref ref-type="bibr" rid="fevr.REF.shastry.1997.217">Shastry &#x00026; Trese 1997</xref>, <xref ref-type="bibr" rid="fevr.REF.decrecchio.1998.315">de Crecchio et al 1998</xref>, <xref ref-type="bibr" rid="fevr.REF.jiao.2004.878">Jiao et al 2004</xref>] </p>
          </list-item>
          <list-item>
            <p>Osteoporosis-pseudoglioma syndrome (OPPG) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/259770">259770</ext-link>) [<xref ref-type="bibr" rid="fevr.REF.gong.2001.513">Gong et al 2001</xref>] </p>
          </list-item>
        </list>
        <p>Missense mutations within the first few exons of <italic toggle="yes">LRP5</italic> have been described in the following autosomal dominant disorders characterized by high bone mass:</p>
        <list list-type="bullet">
          <list-item>
            <p>High bone mass (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/601884">601884</ext-link>) </p>
          </list-item>
          <list-item>
            <p>Endosteal hyperostosis (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/144750">144750</ext-link>) </p>
          </list-item>
          <list-item>
            <p>Osteopetrosis (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607634">607634</ext-link>) [<xref ref-type="bibr" rid="fevr.REF.boyden.2002.1513">Boyden et al 2002</xref>, <xref ref-type="bibr" rid="fevr.REF.little.2002.11">Little et al 2002</xref>, <xref ref-type="bibr" rid="fevr.REF.vanwesenbeeck.2003.763">Van Wesenbeeck et al 2003</xref>] </p>
          </list-item>
        </list>
      </sec>
      <sec id="fevr.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Familial exudative vitreoretinopathy (FEVR) can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner. The mode of inheritance cannot be distinguished by clinical examination alone.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Autosomal dominant FEVR</bold> is the most common of the three modes of inheritance. </p>
          </list-item>
          <list-item>
            <p><bold>Autosomal recessive FEVR</bold> is caused by mutations in <italic toggle="yes">LRP5</italic> [<xref ref-type="bibr" rid="fevr.REF.shastry.1997.217">Shastry &#x00026; Trese 1997</xref>, <xref ref-type="bibr" rid="fevr.REF.decrecchio.1998.315">de Crecchio et al 1998</xref>, <xref ref-type="bibr" rid="fevr.REF.jiao.2004.878">Jiao et al 2004</xref>] (see <xref ref-type="sec" rid="fevr.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>). </p>
          </list-item>
          <list-item>
            <p><bold>X-linked FEVR</bold> is one of the <related-object link-type="booklink" source-id="gene" document-id="norrie" document-type="chapter"><italic toggle="yes">NDP</italic>-related retinopathies</related-object>, a range of phenotypes caused by mutations in <italic toggle="yes">NDP</italic> that includes X-linked FEVR [<xref ref-type="bibr" rid="fevr.REF.chen.1993.180">Chen et al 1993</xref>] and Norrie disease. </p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="i-p" document-type="chapter">Incontinentia pigmenti</related-object> (IP) is a rare X-linked dominant disorder affecting the skin, hair, teeth, nails, and eyes. The eye phenotype is present in one third of affected individuals and resembles FEVR. The other findings of IP distinguish it from FEVR.</p>
        <p>Acquired disorders that resemble adFEVR:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Retinopathy of prematurity (ROP),</bold> a sporadic disorder, is the best phenocopy for FEVR. ROP is characterized by failure of the peripheral retinal vasculature to develop, partly as a result of premature birth prior to the completion of retinal vascularization. In some infants with ROP, retinal neovascularization and cicatricial sequelae appear similar to those seen in individuals with FEVR. The history of prematurity and the lack of a family history of FEVR help to distinguish ROP from FEVR. </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="norrie" document-type="chapter"><bold>Coats disease, persistent fetal vasculature syndrome</bold></related-object><bold>,</bold> and <bold>toxocariasis</bold> have distinctive clinical pictures that may resemble features of the FEVR phenotype, including peripheral retinal fibrovascular mass, retrolental membranes, and exudative detachment. </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Coats disease</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/300216">300216</ext-link>) is characterized by severe retinal telangiectasia. Abnormal vessels can be present throughout the fundus, producing massive exudates that may lead to retinal detachment. It is commonly seen unilaterally in boys. </p>
              </list-item>
              <list-item>
                <p><bold>Persistent fetal vasculature syndrome or persistent hyperplastic primary vitreous (PHPV)</bold> is characterized by retrolental fibrovascular membranes reminiscent of Norrie disease (see <related-object link-type="booklink" source-id="gene" document-id="norrie" document-type="chapter"><italic toggle="yes">NDP</italic>-Related Retinopathies</related-object>). It is observed in full-term infants and is attributed to failure of regression of the hyaloid vasculature. Involvement is usually unilateral but can be bilateral. Occurrence is usually sporadic but occasionally familial. In contrast to FEVR, the involved eyes are often microphthalmic. Clinical features of abnormal hyaloid artery regression, the physiologic process thought to underlie PHPV, are also seen in some persons with FEVR. In one family with autosomal recessive FEVR, affected family members had a tuft of gliotic tissue at the disc (Bergmeister's papillae) or central vitreous opacity extending from the posterior pole to the lens suggestive of a persistent hyaloid artery [<xref ref-type="bibr" rid="fevr.REF.downey.2006.1163">Downey et al 2006</xref>]. </p>
              </list-item>
              <list-item>
                <p><bold>Toxocariasis</bold> is an acquired, usually unilateral, infestation with the round-worm <italic toggle="yes">Toxocara canis</italic>. In one form, a peripheral granulomatous mass develops. Retinal traction may ensue, forming a retinal fold. The uveitis that can be associated with toxocariasis is not a feature of FEVR. </p>
              </list-item>
            </list>
          </list-item>
        </list>
      </sec>
      <sec id="fevr.Management">
        <title>Management</title>
        <sec id="fevr.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with autosomal dominant familial exudative vitreoretinopathy (adFEVR), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ophthalmologic examination, including indirect ophthalmoscopy and scleral depression </p>
            </list-item>
            <list-item>
              <p>Fundus fluorescein angiography, which increases the detection rate of peripheral avascularity in asymptomatic affected individuals [<xref ref-type="bibr" rid="fevr.REF.ober.1980.112">Ober et al 1980</xref>] </p>
            </list-item>
          </list>
        </sec>
        <sec id="fevr.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Retinal avascularity per se often requires no treatment; however, it can induce ischemia, leading to neovascularization of the retinal periphery, which can be treated with prophylactic cryotherapy or argon laser photocoagulation to attempt to induce regression of the new vessels. Similar treatments are used to treat retinal holes and areas of retinal exudate to prevent retinal detachment.</p>
          <p>Rhegmatogenous retinal detachments produced by retinal traction are repaired surgically using conventional methods, but the prognosis is guarded. </p>
          <p>Exudative retinal detachments may be stabilized with cryotherapy, but the prognosis is poor.</p>
        </sec>
        <sec id="fevr.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>The arc of peripheral retinal avascularity, thought to be an aberration of retinal development, is not preventable using current treatments. </p>
        </sec>
        <sec id="fevr.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Patients with FEVR associated with reduced bone density would be expected to benefit from drugs used to treat osteoporosis, although long-term data demonstrating an increase in bone density in these patients is not yet available [<xref ref-type="bibr" rid="fevr.REF.downey.2006.1163">Downey et al 2006</xref>]. </p>
        </sec>
        <sec id="fevr.Surveillance">
          <title>Surveillance</title>
          <p>Children who are at risk based on family history should undergo regular fundus examination to evaluate for the development of retinal neovascularization, traction, or exudate. </p>
          <p>Asymptomatic individuals with a small region of peripheral avascularity may require annual review only. Those with active neovascularization or exudate may well require treatment and close observation thereafter.</p>
          <p>Individuals with retinal traction require review at intervals depending on the degree of stability of the clinical findings. The frequency of the review varies by individual depending on the assessment of the examining clinician.</p>
        </sec>
        <sec id="fevr.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Relatives at risk benefit from fundus examination and, ideally, fundus fluorescein angiography to identify any characteristic lesions. Prophylaxis in the form of peripheral retinal ablation with laser photocoagulation or cryotherapy depends on the individual's age and the progression of the lesion.</p>
          <p>If the pathogenic mutation has been identified in an affected family member, molecular genetic testing of at-risk family members may be useful: relatives who do not have the family-specific mutation do not need regular retinal examinations. </p>
          <p>See <xref ref-type="sec" rid="fevr.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="fevr.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Vascular endothelial growth factor (VEGF) inhibitors are currently in widespread use for acquired retinal diseases with a neovascular or exudative component. An as-yet unpublished study presented information on six children with FEVR and sight-threatening retinal neovascularization and exudate who had failed to stabilize with conventional treatments [<xref ref-type="bibr" rid="fevr.REF.drenser.2006.1">Drenser 2006</xref>]. Treatment with pegaptanib sodium intravitreal injection resulted in a sustained decrease in exudate over six months; however, retinal traction continued to progress; in some eyes this appeared to be initiated by VEGF inhibition. The long-term effects of VEGF inhibition on the eye and the effects of VEGF inhibition in a pediatric population are currently unknown. </p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="fevr.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="fevr.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Autosomal dominant familial exudative vitreoretinopathy (adFEVR) is inherited in an autosomal dominant manner. </p>
        </sec>
        <sec id="fevr.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with adFEVR have inherited the mutation from a parent who may or may not be affected. </p>
              <list list-type="bullet">
                <list-item>
                  <p>Because of reduced penetrance, it is common for such parents to have no visual complications and thus be undiagnosed. </p>
                </list-item>
                <list-item>
                  <p>The mutation may be in an (as-yet) unidentified gene.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A proband with adFEVR may have the disorder as the result of a <italic toggle="yes">de novo</italic> gene mutation. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutations is currently unknown. </p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> mutation include examination by fundus fluorescein angiography and molecular genetic testing if a disease-causing mutation has been identified in the family. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents. </p>
            </list-item>
            <list-item>
              <p>If a parent of the proband has a disease-causing mutation, the risk to the sibs of inheriting the mutation is 50%. </p>
              <list list-type="bullet">
                <list-item>
                  <p>If the sib inherits the mutation, it is not possible to predict whether symptoms will occur. If symptoms do occur, it is not possible to predict the age of onset or severity of symptoms. </p>
                </list-item>
                <list-item>
                  <p>Initial studies have shown that up to 90% of individuals with adFEVR can be asymptomatic. </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If a pathogenic mutation has not been identified in the proband and both parents have normal findings on fundus fluorescein angiography, the risk to the sibs of a proband for adFEVR is low. </p>
            </list-item>
            <list-item>
              <p>Although no instances of germline mosaicism have been reported, it remains a possibility. </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with adFEVR has a 50% chance of inheriting the mutation. </p>
            </list-item>
            <list-item>
              <p>If the offspring inherits the mutation, it is not possible to predict whether symptoms will occur. If symptoms do occur, it is not possible to predict the age of onset or severity. </p>
            </list-item>
            <list-item>
              <p>Up to 90% of individuals with adFEVR can be asymptomatic. </p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent has a disease-causing mutation, his or her family members are at risk. </p>
        </sec>
        <sec id="fevr.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="fevr.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Possible complex inheritance of FEVR.</bold> While no conclusive evidence is available, some anecdotal findings suggest that the pattern of inheritance of FEVR may be more complex than previously thought (see <xref ref-type="sec" rid="fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>). </p>
          <p><bold>Genetic counseling for disorders with reduced penetrance.</bold> Reduced penetrance and the likelihood of additional (as-yet unidentified) genes associated with adFEVR result in significant difficulty in determining which at-risk family members have and have not inherited a pathogenic mutation. Early studies suggested that approximately 50% of individuals with adFEVR were asymptomatic [<xref ref-type="bibr" rid="fevr.REF.benson.1995.473">Benson 1995</xref>]; however, based on limited data from molecular testing for asymptomatic at-risk family members in research studies, this figure appears to be much higher, perhaps as high as 90%. Additional studies may identify penetrance to be mutation specific. </p>
          <p><bold>Genetic counseling for disorders with genetic heterogeneity.</bold> Because the autosomal dominant, autosomal recessive, and X-linked forms of FEVR cannot be distinguished by ophthalmologic examination alone, determining the mode of inheritance for a particular family can be difficult, and for the simplex case, may not be possible. </p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder and/or the disease causing mutation, it is possible that the proband has a <italic toggle="yes">de novo</italic> mutation or the parent has reduced penetrance. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. </p>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="fevr.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the disease-causing mutation has been identified in the family, prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks&#x02019; gestation) or chorionic villus sampling (usually performed at ~10-12 weeks&#x02019; gestation).</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p>Requests for prenatal testing for conditions such as adFEVR are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutation has been identified.</p>
        </sec>
      </sec>
      <sec id="fevr.Resources">
        <title>Resources</title>
      </sec>
      <sec id="fevr.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="fevr.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The primary pathologic process in autosomal dominant familial exudative vitreoretinopathy (adFEVR) is believed to be a premature arrest of retinal angiogenesis/vasculogenesis or retinal vascular differentiation, leading to incomplete vascularization of the peripheral retina. To date, mutations in four genes have been shown to cause FEVR: <italic toggle="yes">NDP</italic> (encoding norrin) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/300658">300658</ext-link>) (X-linked see <related-object link-type="booklink" source-id="gene" document-id="norrie" document-type="chapter"><italic toggle="yes">NDP</italic>-Related Disorders</related-object>), <italic toggle="yes">FZD4</italic> (dominant), <italic toggle="yes">LRP5</italic> (dominant and recessive) and <italic toggle="yes">TSPAN12</italic> (dominant). Each of the encoded proteins is a component of the norrin/&#x003b2;-catenin signaling pathway (also referred to as the norrin/frizzled-4 pathway). In this pathway, the ligand norrin binds to a receptor complex consisting of the receptor frizzled-4, the co-receptor low-density lipoprotein receptor-related protein-5, and the auxiliary protein tetraspanin-12. In the absence of norrin binding, signaling is not activated. This results in cytoplasmic &#x003b2;-catenin becoming phosphorylated and targeted for degradation through the ubiquitin-proteasome pathway. As a result, prospective target genes remain repressed. Signaling is activated by norrin binding to the frizzled-4, LRP5 and TSPAN12 receptor complex. This complex triggers a signal which inhibits the destruction of &#x003b2;-catenin, allowing its cytoplasmic levels to increase. Subsequently, &#x003b2;-catenin enters the nucleus where it interacts with the T-cell factor (TCF)/lymphoid enhancing factor (LEF) family of transcription factors to turn on the expression of norrin target genes. This signaling pathway shares many similarities to the canonic Wnt/&#x003b2;-catenin pathway except that norrin substitutes Wnt as the ligand and no tetraspanins have been linked to Wnt/&#x003b2;-catenin signaling. Identifying new FEVR-related genes therefore provides an ideal opportunity to discover new components of this important signaling pathway [<xref ref-type="bibr" rid="fevr.REF.xu.2004.883">Xu et al 2004</xref>, <xref ref-type="bibr" rid="fevr.REF.junge.2009.299">Junge et al 2009</xref>, <xref ref-type="bibr" rid="fevr.REF.ye.2010.417">Ye et al 2010</xref>].</p>
          <sec id="fevr.FZD4">
            <title>
              <italic toggle="yes">FZD4</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">FZD4</italic> mRNA is 7,394 bp long and comprises two exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fevr" object-id="fevr.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Types of disease-causing mutations identified in <italic toggle="yes">FZD4</italic> include missense changes, nonsense changes, insertions, and deletions; no splice site mutations have been identified. The majority of deletions and insertions result in a frameshift error in the mRNA, but it is not known whether these aberrant mRNAs are targeted for nonsense-mediated mRNA decay or if they produce prematurely terminated truncated proteins. </p>
            <table-wrap id="fevr.T.selected_fzd4_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 2.</label>
              <caption>
                <p>Selected <italic toggle="yes">FZD4</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1250G&#x0003e;A&#x000a0;<sup>1</sup></td>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Arg417Gln</td>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="4" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_012193.3">NM_012193.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_036325.2">NP_036325.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.205C&#x0003e;T&#x000a0;<sup>2</sup></td>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.His69Tyr</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1463G&#x0003e;A</td>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Gly488Asp</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1501_1502delCT</td>
                    <td headers="hd_b_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Leu501SerfsTer533</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="fevr.TF.2">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="fevr.TF.2.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>).</p>
                </fn>
                <fn id="fevr.TF.2.2">
                  <p>1. Associated with a more severe phenotype when in <italic toggle="yes">cis</italic> with <italic toggle="yes">LRP5</italic>
<xref ref-type="table" rid="fevr.T.selected_lrp5_pathogenic_variants">c.1330C&#x0003e;T</xref> mutation (see <xref ref-type="sec" rid="fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>, <bold>Possible complex inheritance of FEVR</bold>).</p>
                </fn>
                <fn id="fevr.TF.2.3">
                  <p>2. Associated with a more severe ocular phenotype when in <italic toggle="yes">trans</italic> with the c.1463G&#x0003e;A mutation (see <xref ref-type="sec" rid="fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>, <bold>Possible complex inheritance of FEVR</bold>).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The 537-amino acid protein frizzled-4 is a member of the frizzled family of seven-pass transmembrane receptors that bind Wnt proteins [<xref ref-type="bibr" rid="fevr.REF.huang.2004.234">Huang &#x00026; Klein 2004</xref>]. However, frizzled-4 is the only member of the frizzled family that functions in the norrin/&#x003b2;-catenin pathway. Evidence suggests that this pathway is the one underlying FEVR and is triggered by the binding of norrin rather than a Wnt ligand to a receptor complex comprising frizzled-4, LRP5, and tetraspanin12 [<xref ref-type="bibr" rid="fevr.REF.xu.2004.883">Xu et al 2004</xref>, <xref ref-type="bibr" rid="fevr.REF.junge.2009.299">Junge et al 2009</xref>]. </p>
            <p><bold>Abnormal gene product.</bold> Many of the mutations in frizzled-4 result in premature termination codons (PTCs). The most likely outcome for mutations resulting in PTCs is haploinsufficiency induced by nonsense-mediated mRNA decay. However, if the PTC is not followed by a downstream intron, as is the case for all the frameshift mutations identified in frizzled-4, the mRNAs can escape this process, enabling them to be translated into truncated mutant proteins. The precise effect of PTCs on frizzled-4 has not been investigated; thus it is not known whether an abnormal gene product is created. However, a study in which a truncated mutant frizzled-4 protein (p.Leu501fsTer533) was created in vitro showed that the mutant protein is not located in its usual position within the cell membrane but is trapped within the endoplasmic reticulum [<xref ref-type="bibr" rid="fevr.REF.robitaille.2002.326">Robitaille et al 2002</xref>, <xref ref-type="bibr" rid="fevr.REF.kaykas.2004.52">Kaykas et al 2004</xref>]. This mutant protein also trapped the wild-type protein within the cell and appeared to act in a dominant-negative manner [<xref ref-type="bibr" rid="fevr.REF.kaykas.2004.52">Kaykas et al 2004</xref>]. </p>
            <p>The majority of the frizzled-4 missense mutations appear to be in functional sites, suggesting that they knock out the function of the protein. For example, in vitro experiments have shown that missense mutations in the CRD domain (p.Met105Val and p.Met157Val) reduce the ability of frizzled-4 to bind norrin and to activate the &#x003b2;-catenin pathway [<xref ref-type="bibr" rid="fevr.REF.xu.2004.883">Xu et al 2004</xref>]. </p>
          </sec>
          <sec id="fevr.LRP5">
            <title><italic toggle="yes">LRP5</italic>
</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">LRP5</italic> mRNA is 5,161 bp long and comprises 23 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fevr" object-id="fevr.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> All types of disease-causing mutations have been identified in <italic toggle="yes">LRP5</italic>: missense changes, nonsense changes, insertions, deletions, and splice site mutations. The majority of deletions, insertions, and splice mutations result in a frameshift error in the mRNA, but it is not known whether these aberrant mRNAs are targeted for nonsense-mediated mRNA decay or if they produce prematurely terminated truncated proteins. </p>
            <table-wrap id="fevr.T.selected_lrp5_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 3.</label>
              <caption>
                <p>Selected <italic toggle="yes">LRP5</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.518C&#x0003e;T</td>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Thr173Met</td>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_3" align="left" valign="middle" rowspan="5" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002335.2">NM_002335.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_002326.2">NP_002326.2</ext-link></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1330C&#x0003e;T</td>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Arg444Cys&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.4081T&#x0003e;G</td>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Cys1361Gly</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.4099G&#x0003e;A</td>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Glu1367Lys</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.3502T&#x0003e;C</td>
                    <td headers="hd_b_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Tyr1168His</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="fevr.TF.3">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="fevr.TF.3.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>).</p>
                </fn>
                <fn id="fevr.TF.3.2">
                  <p>1. Associated with a more severe phenotype when in <italic toggle="yes">cis</italic> with <italic toggle="yes">FZD4</italic>
<xref ref-type="table" rid="fevr.T.selected_fzd4_pathogenic_variants">c.1250G&#x0003e;A</xref> mutation (see <xref ref-type="sec" rid="fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>, <bold>Possible complex inheritance of FEVR</bold>).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">LRP5</italic> encodes a 1,615-amino acid single-pass transmembrane receptor, termed low-density lipoprotein receptor-related protein 5. It partners with frizzled receptors (e.g., frizzled-4) to bind Wnt proteins [<xref ref-type="bibr" rid="fevr.REF.he.2004.1663">He et al 2004</xref>]. LRP5 also functions in the norrin/&#x003b2;-catenin pathway. Evidence suggests that this pathway is the one underlying FEVR and is triggered by the binding of norrin rather than a Wnt ligand to a receptor complex comprising frizzled-4, LRP5, and tetraspanin12.</p>
            <p><bold>Abnormal gene product.</bold> The <italic toggle="yes">LRP5</italic> mutations identified in individuals with adFEVR are predicted to result in functional haploinsufficiency of the protein. Most nonsense and frameshift mutations are likely to undergo nonsense-mediated mRNA decay or produce truncated proteins that are incorrectly transported within the cell; however, no direct evidence exists. In vitro cell-based assays have shown that the adFEVR missense mutations p.Tyr1168His and p.Cys1361Gly affect the transduction of &#x003b2;-catenin signaling upon binding of either Wnt or norrin. However, two other adFEVR-related mutations (p.Thr173Met and p.Glu1367Lys) tested in a similar manner did not show any effect. When proteins with the adFEVR-related mutations p.Thr173Met, p.Glu1367Lys, p.Tyr1168His, and p.Cys1361Gly were cotransfected with wild-type LRP5 protein, none of them interfered with wild-type Wnt/&#x003b2;-catenin signaling, arguing against a dominant-negative effect for these mutations on Wnt signaling [<xref ref-type="bibr" rid="fevr.REF.ai.2005.741">Ai et al 2005</xref>]. </p>
          </sec>
          <sec id="fevr.TSPAN12">
            <title>
              <italic toggle="yes">TSPAN12</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">TSPAN12</italic> mRNA is 2579 bp long and comprises eight exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fevr" object-id="fevr.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> The types of disease-causing mutations identified in <italic toggle="yes">TSPAN12</italic> include missense changes, nonsense changes, insertions, deletions, and splice site mutations. The majority of deletions, insertions, and splice mutations result in a frameshift error in the mRNA, but it is not known whether these aberrant mRNAs are targeted for nonsense-mediated mRNA decay or if they produce prematurely terminated truncated proteins. </p>
            <table-wrap id="fevr.T.selected_tspan12_pathogenic_varia" position="anchor" orientation="portrait">
              <label>Table 4.</label>
              <caption>
                <p>Selected <italic toggle="yes">TSPAN12</italic> Pathogenic Variants</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_b_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_b_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                  <tr>
                    <td headers="hd_b_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.709G&#x0003e;C</td>
                    <td headers="hd_b_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ala237Pro&#x000a0;<sup>1</sup></td>
                    <td headers="hd_b_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_012338.3">NM_012338.3</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_036470.1">NP_036470.1</ext-link></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="fevr.TF.4">
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
                </fn>
                <fn id="fevr.TF.4.1">
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>).</p>
                </fn>
                <fn id="fevr.TF.4.2">
                  <p>1. Common in the Netherlands</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">TSPAN12</italic> encodes a 305-amino acid protein containing four transmembrane-spanning domains, termed tetraspanin12. It forms a component of the norrin-LRP5-FZD4 signaling complex; cell-based assays have shown that it enhances the level of norrin/&#x003b2;-catenin signaling [<xref ref-type="bibr" rid="fevr.REF.junge.2009.299">Junge et al 2009</xref>].</p>
            <p><bold>Abnormal gene product.</bold> The <italic toggle="yes">TSPAN12</italic> mutations identified in individuals with adFEVR are predicted to result in functional haploinsufficiency of the protein. Most nonsense and frameshift mutations are predicted to undergo nonsense-mediated mRNA decay or produce truncated proteins that are incorrectly transported within the cell.</p>
          </sec>
        </sec>
      </sec>
      <sec id="fevr.References">
        <title>References</title>
        <sec id="fevr.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="fevr.Literature_Cited.reflist0">
            <ref id="fevr.REF.ai.2005.741">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heeger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartels</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schelling</surname>
                    <given-names>DK</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <year>2005</year>
                <volume>77</volume>
                <fpage>741</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">16252235</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.benson.1995.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benson</surname>
                    <given-names>WE</given-names>
                  </name>
                </person-group>
                <article-title>Familial exudative vitreoretinopathy.</article-title>
                <source>Trans Am Ophthalmol Soc</source>
                <year>1995</year>
                <volume>93</volume>
                <fpage>473</fpage>
                <lpage>521</lpage>
                <pub-id pub-id-type="pmid">8719692</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.boonstra.2009.4379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boonstra</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuil</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wijs</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Donk</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikopoulos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilanus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2009</year>
                <volume>50</volume>
                <fpage>4379</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">19324841</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.bottomley.2006.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Comment on 'cosegregation of two unlinked mutant alleles in some cases of autosomal dominant familial exudative vitreoretinopathy'.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2006</year>
                <volume>14</volume>
                <fpage>6</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16319824</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.boyden.2002.1513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boyden</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belsky</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitzner</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farhi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitnick</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Insogna</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <article-title>High bone density due to a mutation in LDL-receptor-related protein 5.</article-title>
                <source>N Engl J Med</source>
                <year>2002</year>
                <volume>346</volume>
                <fpage>1513</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12015390</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.chen.1993.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ZY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battinelli</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fielder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bundey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breakefield</surname>
                    <given-names>XO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>IW</given-names>
                  </name>
                </person-group>
                <article-title>A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy.</article-title>
                <source>Nat Genet</source>
                <year>1993</year>
                <volume>5</volume>
                <fpage>180</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8252044</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.decrecchio.1998.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Crecchio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunziata</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzeo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greco</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventruto</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccodicola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miano</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Urso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldi</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavaliere</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelluccio</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity.</article-title>
                <source>Clin Genet</source>
                <year>1998</year>
                <volume>54</volume>
                <fpage>315</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">9831343</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.downey.2006.1163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheridan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilmour</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agrawal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradbury</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.</article-title>
                <source>Br J Ophthalmol</source>
                <year>2006</year>
                <volume>90</volume>
                <fpage>1163</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16929062</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.downey.2001.778">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keen</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansfield</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamashmus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <article-title>A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13.</article-title>
                <source>Am J Hum Genet</source>
                <year>2001</year>
                <volume>68</volume>
                <fpage>778</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11179025</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.drenser.2006.1">
              <mixed-citation publication-type="confproc">Drenser KA. Pharmacologic therapy for pediatric retinal vascular disease. Las Vegas, NV: The Annual Meeting of the American Academy of Ophthalmology; 2006</mixed-citation>
            </ref>
            <ref id="fevr.REF.drenser.2009.1649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenser</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dailey</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinekar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene.</article-title>
                <source>Arch Ophthalmol.</source>
                <year>2009</year>
                <volume>127</volume>
                <fpage>1649</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20008721</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.gong.2001.513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slee</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rawadi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roman-Roman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reginato</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glorieux</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zacharin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oexle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcelino</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suwairi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heeger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabatakos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apte</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adkins</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allgrove</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arslan-Kirchner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batch</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boles</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borrone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carle</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floege</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halfhide</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jans</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juppner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keppler-Noreuil</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschuetter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaCombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemyre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letteboer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesar</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romanengo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steichen-Gersdorf</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Boogaard</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Votruba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.</article-title>
                <source>Cell</source>
                <year>2001</year>
                <volume>107</volume>
                <fpage>513</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11719191</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.he.2004.1663">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semenov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <article-title>LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.</article-title>
                <source>Development</source>
                <year>2004</year>
                <volume>131</volume>
                <fpage>1663</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">15084453</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.huang.2004.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <article-title>The Frizzled family: receptors for multiple signal transduction pathways.</article-title>
                <source>Genome Biol</source>
                <year>2004</year>
                <volume>5</volume>
                <fpage>234</fpage>
                <pub-id pub-id-type="pmid">15239825</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.jia.2010.1341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jia</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>XX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>WZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Novel frizzled-4 gene mutations in chinese patients with familial exudative vitreoretinopathy.</article-title>
                <source>Arch Ophthalmol.</source>
                <year>2010</year>
                <volume>128</volume>
                <fpage>1341</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20938005</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.jiao.2004.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventruto</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejtmancik</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.</article-title>
                <source>Am J Hum Genet</source>
                <year>2004</year>
                <volume>75</volume>
                <fpage>878</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">15346351</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.junge.2009.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Junge</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.</article-title>
                <source>Cell.</source>
                <year>2009</year>
                <volume>139</volume>
                <fpage>299</fpage>
                <lpage>311</lpage>
                <pub-id pub-id-type="pmid">19837033</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.kaykas.2004.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaykas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang-Snyder</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heroux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouvier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moon</surname>
                    <given-names>RT</given-names>
                  </name>
                </person-group>
                <article-title>Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization.</article-title>
                <source>Nat Cell Biol</source>
                <year>2004</year>
                <volume>6</volume>
                <fpage>52</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14688793</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.kondo.2003.1291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahira</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity.</article-title>
                <source>Br J Ophthalmol</source>
                <year>2003</year>
                <volume>87</volume>
                <fpage>1291</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">14507768</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.kondo.2011.1095">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshinaga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tawara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahira</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the TSPAN12 gene in Japanese patients with familial exudative vitreoretinopathy.</article-title>
                <source>Am J Ophthalmol.</source>
                <year>2011</year>
                <volume>151</volume>
                <fpage>1095</fpage>
                <lpage>1100</lpage>
                <pub-id pub-id-type="pmid">21334594</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.little.2002.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Little</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carulli</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Mastro</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupuis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Folz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manning</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swain</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eustace</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lappe</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spitzer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zweier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braunschweiger</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benchekroun</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adair</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chee</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>FitzGerald</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulig</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzellas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franklin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nogues</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anisowicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lomedico</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Recker</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Eerdewegh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Recker</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.</article-title>
                <source>Am J Hum Genet</source>
                <year>2002</year>
                <volume>70</volume>
                <fpage>11</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11741193</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.macdonald.2005.363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macfarlane</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity.</article-title>
                <source>Clin Genet</source>
                <year>2005</year>
                <volume>67</volume>
                <fpage>363</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15733276</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.miyakubo.1984.1524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyakubo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyakubo</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Retinal vascular pattern in familial exudative vitreoretinopathy.</article-title>
                <source>Ophthalmology</source>
                <year>1984</year>
                <volume>91</volume>
                <fpage>1524</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">6084219</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.nallathambi.2006.1086">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nallathambi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shukla</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajendran</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Namperumalsamy</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muthulakshmi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sundaresan</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Identification of novel FZD4 mutations in Indian patients with familial exudative vitreoretinopathy.</article-title>
                <source>Mol Vis</source>
                <year>2006</year>
                <volume>12</volume>
                <fpage>1086</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17093393</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.nikopoulos.2010a.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikopoulos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venselaar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riveiro-Alvarez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boonstra</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hooymans</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shears</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wijs</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Essen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilanus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                </person-group>
                <article-title>Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP.</article-title>
                <source>Hum Mutat.</source>
                <year>2010a</year>
                <volume>31</volume>
                <fpage>656</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20340138</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.nikopoulos.2010b.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikopoulos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilissen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoischen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boonstra</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blokland</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arts</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieskamp</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilanus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouwhuis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veltman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010b</year>
                <volume>86</volume>
                <fpage>240</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20159111</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.ober.1980.112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ober</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sehmi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant exudative vitreoretinopathy.</article-title>
                <source>Br J Ophthalmol</source>
                <year>1980</year>
                <volume>64</volume>
                <fpage>112</fpage>
                <lpage>120</lpage>
                <pub-id pub-id-type="pmid">7362811</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.omoto.2004.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Omoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitahara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueoka</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R).</article-title>
                <source>Ophthalmic Genet</source>
                <year>2004</year>
                <volume>25</volume>
                <fpage>81</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15370539</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.poulter.2010.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poulter</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilmour</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kearns</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruddle</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierce</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markham</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>86</volume>
                <fpage>248</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20159112</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.qin.2005.104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahira</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.</article-title>
                <source>Hum Mutat</source>
                <year>2005</year>
                <volume>26</volume>
                <fpage>104</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">15981244</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.robitaille.2002.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robitaille</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaykas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheldahl</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeisler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dube</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singaraja</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guernsey</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoskin-Mott</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimstone</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moon</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.</article-title>
                <source>Nat Genet</source>
                <year>2002</year>
                <volume>32</volume>
                <fpage>326</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12172548</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.robitaille.2011.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robitaille</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beis</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatlidil</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheidow</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arthur</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyons</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaakkola</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsilou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guernsey</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <article-title>The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease.</article-title>
                <source>Br J Ophthalmol.</source>
                <year>2011</year>
                <volume>95</volume>
                <fpage>574</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21097938</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.shastry.1997.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity.</article-title>
                <source>Am J Med Genet</source>
                <year>1997</year>
                <volume>69</volume>
                <fpage>217</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9056564</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.shastry.2004.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Cosegregation of two unlinked mutant alleles in some cases of autosomal dominant familial exudative vitreoretinopathy.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2004</year>
                <volume>12</volume>
                <fpage>79</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">14560311</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.shukla.2003.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shukla</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sudheer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramasamy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perumalsamy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Familial exudative vitreoretinopathy (FEVR). Clinical profile and management.</article-title>
                <source>Indian J Ophthalmol</source>
                <year>2003</year>
                <volume>51</volume>
                <fpage>323</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14750620</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.tasman.1981.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tasman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augsburger</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caputo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesley</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <article-title>Familial exudative vitreoretinopathy.</article-title>
                <source>Trans Am Ophthalmol Soc</source>
                <year>1981</year>
                <volume>79</volume>
                <fpage>211</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">7342402</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.toomes.2004a.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towns</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodruff</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory-Evans</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory-Evans</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.</article-title>
                <source>Am J Hum Genet</source>
                <year>2004a</year>
                <volume>74</volume>
                <fpage>721</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15024691</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.toomes.2004b.2083">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appukuttan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stout</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flaxel</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <article-title>Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <year>2004b</year>
                <volume>45</volume>
                <fpage>2083</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15223780</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.vannouhuys.1982.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <article-title>Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.</article-title>
                <source>Doc Ophthalmol</source>
                <year>1982</year>
                <volume>54</volume>
                <fpage>1</fpage>
                <lpage>414</lpage>
                <pub-id pub-id-type="pmid">6897033</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.vannouhuys.1991.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <article-title>Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy.</article-title>
                <source>Am J Ophthalmol</source>
                <year>1991</year>
                <volume>111</volume>
                <fpage>34</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">1985487</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.vanwesenbeeck.2003.763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Wesenbeeck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleiren</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gram</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beals</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benichou</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scopelliti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Key</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renton</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartels</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vernejoul</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bollerslev</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.</article-title>
                <source>Am J Hum Genet</source>
                <year>2003</year>
                <volume>72</volume>
                <fpage>763</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12579474</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.xu.2004.883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabdoub</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smallwood</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.</article-title>
                <source>Cell</source>
                <year>2004</year>
                <volume>116</volume>
                <fpage>883</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">15035989</pub-id>
              </element-citation>
            </ref>
            <ref id="fevr.REF.ye.2010.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.</article-title>
                <source>Trends Mol Med.</source>
                <year>2010</year>
                <volume>16</volume>
                <fpage>417</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">20688566</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="fevr.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="fevr.Suggested_Reading.reflist0">
            <ref id="fevr.REF.toomes.2005.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mintz-Hittner</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <article-title>Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.</article-title>
                <source>Br J Ophthalmol</source>
                <year>2005</year>
                <volume>89</volume>
                <fpage>194</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15665352</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="fevr.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="fevr.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>22 September 2011 (cd) Revision: sequence analysis of <italic toggle="yes">TSPAN12</italic> available clinically </p>
            </list-item>
            <list-item>
              <p>14 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>11 December 2008 (cd) Revision: clinical and prenatal testing available for mutations in <italic toggle="yes">LRP5</italic> and <italic toggle="yes">FZD4</italic>; prenatal testing available for mutations in <italic toggle="yes">FZD4</italic></p>
            </list-item>
            <list-item>
              <p>28 August 2008 (cd) Revision: sequence analysis available clinically</p>
            </list-item>
            <list-item>
              <p>27 August 2007 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>21 March 2005 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>9 September 2004 (ct) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="fevr.1.11" sec-type="figs-and-tables">
        <title/>
        <fig id="fevr.F1" position="float" orientation="portrait">
          <label>Figure 1.</label>
          <caption>
            <p>Classic features of FEVR1A. Fundus fluorescein angiogram showing the temporal retinal periphery of the right eye of a mildly affected person. Black areas to the left of the photograph represent loss of the normal capillary architecture corresponding to a region of retinal avascularity. Adjacent to this are dilated truncated telangictatic vessels leaking fluorescein dye (white patches). On the right of the photograph preserved retinal vessels are straightened as they approach the avascular zone. 1B. Fundus photograph of the right eye from an individual with more severe disease. Extensive vitreoretinal traction distorts the retinal vessels emerging from the optic disc, producing a retinal fold extending across the posterior pole to the temporal periphery.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fevrComposite" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
